Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Oral rimegepant for migraine prevention

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Bipolar disorders

    Research output: Contribution to journalReviewResearchpeer-review

  • John Burn
  • Anne-Marie Axø Gerdes
  • Finlay Macrae
  • Jukka-Pekka Mecklin
  • Gabriela Moeslein
  • Sylviane Olschwang
  • Diane Eccles
  • D Gareth Evans
  • Eamonn R Maher
  • Lucio Bertario
  • Marie-Luise Bisgaard
  • Malcolm G Dunlop
  • Judy W C Ho
  • Shirley V Hodgson
  • Annika Lindblom
  • Jan Lubinski
  • Patrick J Morrison
  • Victoria Murday
  • Raj Ramesar
  • Lucy Side
  • Rodney J Scott
  • Huw J W Thomas
  • Hans F Vasen
  • Gail Barker
  • Gillian Crawford
  • Faye Elliott
  • Mohammad Movahedi
  • Kirsi Pylvanainen
  • Juul T Wijnen
  • Riccardo Fodde
  • Henry T Lynch
  • John C Mathers
  • D Timothy Bishop
  • CAPP2 Investigators
View graph of relations
Observational studies report reduced colorectal cancer in regular aspirin consumers. Randomised controlled trials have shown reduced risk of adenomas but none have employed prevention of colorectal cancer as a primary endpoint. The CAPP2 trial aimed to investigate the antineoplastic effects of aspirin and a resistant starch in carriers of Lynch syndrome, the major form of hereditary colorectal cancer; we now report long-term follow-up of participants randomly assigned to aspirin or placebo.
Original languageEnglish
JournalLancet
Volume378
Issue number9809
Pages (from-to)2081-7
Number of pages7
ISSN0140-6736
DOIs
Publication statusPublished - 2011

    Research areas

  • Adenoma, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Chemoprevention, Colorectal Neoplasms, Hereditary Nonpolyposis, Dietary Carbohydrates, Double-Blind Method, Heterozygote, Humans, Starch

ID: 33281438